SBSB
ESRX

Sullivan, Bruyette, Speros & Blaney’s Express Scripts Holding Company ESRX Stock Holding History

Sullivan, Bruyette, Speros & Blaney’s Portfolio ESRX Stock Details ESRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-4,352
Closed -$413K – 213
2018
Q3 		$413K Buy
4,352
+122
+3% +$10.4K 0.04% 108
2018
Q2 		$327K Buy
4,230
+50
+1% +$3.75K 0.03% 127
2018
Q1 		$289K Sell
4,180
-332
-7% -$25.3K 0.03% 133
2017
Q4 		$337K Sell
4,512
-42
-0.9% -$2.69K 0.03% 127
2017
Q3 		$288K Sell
4,554
-59
-1% -$3.67K 0.03% 129
2017
Q2 		$294K Buy
4,613
+300
+7% +$18.8K 0.03% 123
2017
Q1 		$284K Sell
4,313
-412
-9% -$28.3K 0.03% 117
2016
Q4 		$325K Sell
4,725
-475
-9% -$34K 0.03% 110
2016
Q3 		$367K Sell
5,200
-1,387
-21% -$104K 0.04% 94
2016
Q2 		$499K Buy
+6,587
New +$484K 0.05% 73

Other funds holding ESRX

SEI Investments
SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return
ECM
Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return
BJL
Brighton Jones LLC Seattle, Washington $2.37B AUM 16.36% 1-Year Est. Return
BSPF
British Steel Pension Fund London, United Kingdom $410M AUM 11.96% 1-Year Est. Return
MYAM
Meiji Yasuda Asset Management Tokyo, Japan $2B AUM 22.52% 1-Year Est. Return
AWM
Alterna Wealth Management Houston, Texas $174M AUM 15.45% 1-Year Est. Return
W
Wealthquest Cincinnati, Ohio $1.41B AUM 14.87% 1-Year Est. Return
ACA
Atlas Capital Advisors Jackson, Wyoming $875M AUM
UCFA
United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return
SBL
Sargent Bickham Lagudis Boulder, Colorado $1.22B AUM 14.94% 1-Year Est. Return

Sullivan, Bruyette, Speros & Blaney's ESRX Position: Q4 2018 in Review

Sullivan, Bruyette, Speros & Blaney sold out of Express Scripts Holding Company (ESRX) in Q4 2018, closing a stake of 4,352 shares — an estimated $413K sold.

Sullivan, Bruyette, Speros & Blaney first reported a position in ESRX in Q2 2016 and held it in 10 quarters. The position peaked at $499K in Q2 2016. 16 funds tracked by Wall St. Rank hold ESRX as of Q4 2018.

  • Sullivan, Bruyette, Speros & Blaney reported no remaining Express Scripts Holding Company position as of Q4 2018 after selling out during the quarter.
  • Sullivan, Bruyette, Speros & Blaney sold 4,352 Express Scripts Holding Company shares in Q4 2018, an estimated $413K.
  • Sullivan, Bruyette, Speros & Blaney first reported a position in Express Scripts Holding Company in Q2 2016 and held it in 10 quarters.
  • Sullivan, Bruyette, Speros & Blaney's Express Scripts Holding Company position peaked at $499K in Q2 2016.
  • 16 funds tracked by Wall St. Rank held Express Scripts Holding Company as of Q4 2018.

Based on Sullivan, Bruyette, Speros & Blaney's 13F filing for Q4 2018, filed 7 Feb 2019.